Holistic Diabetes Care in Maryland
Adjusting Your Insulin Pump When Starting a GLP-1 Medication
Starting a GLP-1 medication like Mounjaro or Ozempic? If you use an insulin pump, you may need to adjust your settings. GLP-1s can reduce blood sugar spikes and meal size, making previous doses too strong. Learn how to modify your carb ratio, correction factor, and basal rate to stay safe.
Published
Fulminant Type 1 Diabetes: Sudden Onset, Serious Risk
Fulminant type 1 diabetes develops suddenly and progresses rapidly. Unlike typical type 1 diabetes, A1c may remain normal, and autoantibodies are often absent. Patients can present in DKA without prior warning. Prompt insulin therapy is essential. This rare condition requires careful monitoring, holistic follow-up, and lifelong insulin support starting immediately at diagnosis.
Published
Insulin Pump for Diabetes: Smart Delivery, Better Control
Insulin pumps offer continuous, programmable insulin delivery, reducing glucose highs and lows while improving lifestyle flexibility. This blog explores how smart pumps, especially when paired with CGMs, can enhance diabetes control, support safer sleep, and fit modern lives—from busy professionals to children, athletes, and retirees managing type 1 or insulin-dependent type 2 diabetes.
Published
Type 1 Diabetes: Understanding the Condition and Its Care
Type 1 diabetes is an autoimmune condition that destroys insulin-producing cells in the pancreas. It often appears in childhood but can occur at any age. This blog explains symptoms, diagnosis, daily challenges, and the benefits of personalized care. We explore tools like CGMs, insulin pumps, and holistic strategies to support long-term health and stability.
Published
Comprehensive Endocrine Care in Maryland
Discover comprehensive endocrine care in Maryland with a focus on thyroid, diabetes, cholesterol, weight, and hormone balance. From virtual visits to advanced testing, we offer personalized support with a holistic approach.
Published
Categorized as Endocrinology
Comparing Diabetes Types: T1D, T2D, MODY, LADA, and KPD
Not all diabetes types are the same. This side-by-side guide compares Type 1, Type 2, MODY, LADA, and KPD. Learn how they differ in cause, age of onset, insulin needs, and treatment response—and why accurate diagnosis leads to safer, more personalized, and longer-lasting care from the start.
Published
MODY in Adults: The Overlooked Diabetes Type
Many adults with MODY diabetes are misdiagnosed with type 1 or type 2. This genetic condition often requires different care. Learn how personalized diagnosis and treatment can change outcomes for adults with monogenic diabetes—especially when the signs are subtle and lifelong.
Published
Ketosis-Prone Diabetes: Not Type 1, Not Type 2
Ketosis-prone diabetes causes DKA in patients who don’t fit classic type 1 or 2 profiles. This blog explores Aβ classification, recovery potential, and the need for individualized care. Learn how a smart, nuanced approach can help patients avoid unnecessary lifelong insulin while preventing future DKA.
Published
What Is LADA? Understanding Adult-Onset Type 1 Diabetes
LADA is a form of autoimmune diabetes often mistaken for type 2. It develops slowly but requires a different approach. In Montgomery County, we offer specialized testing and individualized care to manage LADA from multiple angles—preserving beta-cell function, preventing complications, and supporting patients holistically through this misunderstood condition.
Published
Central vs. Peripheral Insulin Resistance
Insulin resistance doesn’t just affect your muscles and liver. It also impacts your brain. In fact, central insulin resistance may appear earlier and silently shape your behavior, cravings, and cognition. Distinguishing central from peripheral insulin resistance helps us approach metabolic issues from multiple angles.
Published
Insulin Resistance in Type 1 Diabetes: Hidden Burden
Insulin resistance isn’t just for type 2 diabetes. Many people with type 1 diabetes (T1D) develop features of insulin resistance as well. This hybrid form is often referred to as double diabetes. It’s more common than previously thought and can dramatically alter the course of care.
Published
Could a Stomach Virus Mimic GLP-1 Agonists?
A curious observation comes up now and then in clinic: a patient with a viral GI illness—typically marked by nausea, loss of appetite, and sometimes transient weight loss—describes symptoms eerily similar to what we see in GLP-1 agonist use. What’s driving this overlap?
Published